Sanofi on Monday said it will pay $3.68 billion to acquire partner Principia Biopharma in a deal that gives the French drugmaker full control over a promising experimental medicine for multiple sclerosis.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,